newsFirst-in-human universal CAR-T therapy trial begins4 December 2020 | By Hannah Balfour (European Pharmaceutical Review)The dose-finding trial will evaluate the safety and activity of UniCAR-T-PSMA in up to 16 patients with advanced relapsed/refractory, PSMA-positive solid tumours.